Treatment of COPD exacerbations

Pharmacologic options and modification of risk factors

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Exacerbations of COPD are a major source of morbidity and mortality, resulting in tremendous increases in healthcare costs. Spirometric testing of at-risk persons can help identify patients early in the disease course who may benefit from early intervention to slow the disease process. Avoidance of irritants, smoking cessation, and use of pharmacologic agents aimed at decreasing airflow obstruction are strategies for reducing the frequency and severity of exacerbations. Patients should be educated about modifiable risk factors, such as cigarette smoking, environmental exposures, improper inhaler technique, influenza and pneumonia vaccination, pulmonary rehabilitation, and use of supplemental oxygen. Early, aggressive interventions are necessary to improve quality of life, decrease hospital admissions, improve morbidity and mortality, and reduce overall healthcare costs.

Original languageEnglish (US)
Pages (from-to)65-75
Number of pages11
JournalPostgraduate medicine
Volume111
Issue number6
DOIs
StatePublished - Jan 1 2002

Fingerprint

Health Care Costs
Chronic Obstructive Pulmonary Disease
Morbidity
Mortality
Irritants
Nebulizers and Vaporizers
Environmental Exposure
Smoking Cessation
Human Influenza
Pneumonia
Vaccination
Rehabilitation
Smoking
Quality of Life
Oxygen
Lung
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Treatment of COPD exacerbations : Pharmacologic options and modification of risk factors. / Blanchard, Amy Renee.

In: Postgraduate medicine, Vol. 111, No. 6, 01.01.2002, p. 65-75.

Research output: Contribution to journalArticle

@article{f7059635008c440180cf4102940fed55,
title = "Treatment of COPD exacerbations: Pharmacologic options and modification of risk factors",
abstract = "Exacerbations of COPD are a major source of morbidity and mortality, resulting in tremendous increases in healthcare costs. Spirometric testing of at-risk persons can help identify patients early in the disease course who may benefit from early intervention to slow the disease process. Avoidance of irritants, smoking cessation, and use of pharmacologic agents aimed at decreasing airflow obstruction are strategies for reducing the frequency and severity of exacerbations. Patients should be educated about modifiable risk factors, such as cigarette smoking, environmental exposures, improper inhaler technique, influenza and pneumonia vaccination, pulmonary rehabilitation, and use of supplemental oxygen. Early, aggressive interventions are necessary to improve quality of life, decrease hospital admissions, improve morbidity and mortality, and reduce overall healthcare costs.",
author = "Blanchard, {Amy Renee}",
year = "2002",
month = "1",
day = "1",
doi = "10.3810/pgm.2002.06.1226",
language = "English (US)",
volume = "111",
pages = "65--75",
journal = "Postgraduate Medicine",
issn = "0032-5481",
publisher = "Medquest Communications LLC",
number = "6",

}

TY - JOUR

T1 - Treatment of COPD exacerbations

T2 - Pharmacologic options and modification of risk factors

AU - Blanchard, Amy Renee

PY - 2002/1/1

Y1 - 2002/1/1

N2 - Exacerbations of COPD are a major source of morbidity and mortality, resulting in tremendous increases in healthcare costs. Spirometric testing of at-risk persons can help identify patients early in the disease course who may benefit from early intervention to slow the disease process. Avoidance of irritants, smoking cessation, and use of pharmacologic agents aimed at decreasing airflow obstruction are strategies for reducing the frequency and severity of exacerbations. Patients should be educated about modifiable risk factors, such as cigarette smoking, environmental exposures, improper inhaler technique, influenza and pneumonia vaccination, pulmonary rehabilitation, and use of supplemental oxygen. Early, aggressive interventions are necessary to improve quality of life, decrease hospital admissions, improve morbidity and mortality, and reduce overall healthcare costs.

AB - Exacerbations of COPD are a major source of morbidity and mortality, resulting in tremendous increases in healthcare costs. Spirometric testing of at-risk persons can help identify patients early in the disease course who may benefit from early intervention to slow the disease process. Avoidance of irritants, smoking cessation, and use of pharmacologic agents aimed at decreasing airflow obstruction are strategies for reducing the frequency and severity of exacerbations. Patients should be educated about modifiable risk factors, such as cigarette smoking, environmental exposures, improper inhaler technique, influenza and pneumonia vaccination, pulmonary rehabilitation, and use of supplemental oxygen. Early, aggressive interventions are necessary to improve quality of life, decrease hospital admissions, improve morbidity and mortality, and reduce overall healthcare costs.

UR - http://www.scopus.com/inward/record.url?scp=0036282760&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036282760&partnerID=8YFLogxK

U2 - 10.3810/pgm.2002.06.1226

DO - 10.3810/pgm.2002.06.1226

M3 - Article

VL - 111

SP - 65

EP - 75

JO - Postgraduate Medicine

JF - Postgraduate Medicine

SN - 0032-5481

IS - 6

ER -